On this episode of Stock Movers:
- Bristol Myers (BMY) shares climb. Bristol Myers Squibb Co.’s experimental drugs for treating a rare endocrine cancer and a deadly form of lung disease showed promise in late-stage studies, a potential boon for the pharmaceutical company’s new product pipeline. Wall Street has been eagerly anticipating both results, as the drugs use novel approaches for hard-to-treat conditions that impair patients’ quality of life and are eventually fatal.
- Adobe (ADBE) shares drop. Wells Fargo Securities downgraded the maker of software for creative professionals by two notches, to underweight from overweight.
- Salesforce (CRM) shares gain. BofA Global Research raised the recommendation on the software company to buy from underperform, pointing to tailwinds from AI adoption.

Salesforce Gains, Adobe Drops, Chipotle Falls on News Starbucks Won't Buy the Company
04:43

Amazon and IonQ Deals; T-Mobile Upgrade
04:29

Amazon-Decart Latest; T-Mobile Upgrade; Sandisk Slide
04:13